Get started
Author

Shigeo Ohba

Observed name: Shigeo OHBA
OpenAlex ID: A5114045498
Temporal Resolution of the Skin Impedance Measurement in Frequency-Domain Method
2006 · Takenori Fukumoto, Gwang-Moon Eom, et al. · IEEE Transactions on Biomedical Engineering · 2
High Resolution Measurement of Time Variation in Skin Impedance Locus
2002 · Takenori FUKUMOTO, Shigeo OHBA, et al. · IEEJ Transactions on Electronics Information and Systems · 2
PDF
An Ultrasonic Probe to Measure Both Radial Arterial Pressure and Diameter at Identical Position for Early Diagnosis of Arteriosclerosis
2018 · Mototaka Arakawa, Takumi Saito, et al. · IEEE International Ultrasonics Symposium · 1
Supplementary table-1 from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
PDF
Supplementary figure-1 from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
PDF
Supplementary figure-5 from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
PDF
Data from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
Data from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
Supplementary figure-2 from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
PDF
Supplementary figure-4 from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
PDF
Supplementary figure-3 from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
PDF
Supplementary table-1 from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
Supplementary figure-3 from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
Supplementary figure-2 from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
Supplementary figure-5 from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
Supplementary figure-1 from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
Supplementary figure-4 from Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
2023 · Joydeep Mukherjee, Tor-Christian Johannessen, et al.
Data from Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process
2023 · Shigeo Ohba, Joydeep Mukherjee, et al.
Supplementary Table S1 from Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process
2023 · Shigeo Ohba, Joydeep Mukherjee, et al.
Supplementary Table S1 from Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process
2023 · Shigeo Ohba, Joydeep Mukherjee, et al.
Data from Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process
2023 · Shigeo Ohba, Joydeep Mukherjee, et al.
IDH1-mutant, alternative lengthening of telomeres (ALT)-dependent gliomas use the deubiquitinase BRCC3 to degrade cytosolic cGAS and avoid cGAS-STING-mediated activation of innate immunity
2022 · Joydeep Mukherjee, Yongjian Tang, et al. · WFNOS 2022 Abstract Book
Targeting amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas
2022 · Shigeo Ohba, Akiyoshi Hirayama, et al. · WFNOS 2022 Abstract Book
ホスホグリセリン酸ムターゼ1はwip1活性の調節を介してdna損傷修復を活性化する【jst・京大機械翻訳】
2020 · Shigeo Ohba, Johannessen Tor-Christian Aase, et al. · Cell Reports
上衣腫の分子分類の重要性: C11orf95-relA融合陰性テント上上衣腫は腫瘍の異種群である【JST・京大機械翻訳】
2018 · Kohei Fukuoka, Yonehiro Kanemura, et al.
Works count: 28
Citation count: 5
H-index: 2
I10-index:
Year
Topic
Type